Cagrilintide Dose Escalation Studies Phase 2 trials evaluated multiple cagrilintide doses to identify the optimal balance between efficacy and tolerability: 0.3 mg weekly Minimal efficacy, excellent tolerability 0.6 mg weekly Moderate effects, good tolerability 1.2 mg weekly Strong efficacy, acceptable side effects 2.4 mg weekly Optimal efficacy-tolerability balance 4.5 mg weekly Excessive GI side effects outweighed benefits The 2.4 mg weekly dose emerged as the standard in phase 3 trials, providing substantial metabolic benefits while maintaining an acceptable side effect profile[6]
Difficulty walking or balance problems : Nerve damage caused by B12 deficiency can lead to difficulty walking, balance problems, and even muscle weakness
Anecdotal reports occasionally include minor issues such as dizziness, nausea, or changes in appetite
I have been very satisfied with the product
Retinoids can increase skin sensitivity, and vitamin C is acidic enough to compromise the stability of copper peptides if used together